Dealing with ALS health crises means doing what needs to be done without thinking about the trauma of it all, writes columnist.
A Phase 2 trial to test the use of nasal spray foralumab for the treatment of ALS has been accepted into the Healey ALS ...
Columnist Dagmar Munn shares her daily exercise program, which she calls "therapeutic movement," with her readers.
Three years after the death of her husband, Craig, from ALS, guest writer Anita Newton struggles with coming home to an empty ...
The FDA has cleared Neurosense to begin its pivotal Phase 3 clinical trial of PrimeC for the treatment of amyotrophic lateral ...
The ALS Association is awarding $2.14 million in grants to help clinics across the U.S. strengthen multidisciplinary care for ...
Columnist Juliet Taylor shares how her late husband's brother Steve always showed up with love and laughter, despite the ...
Because there's no winning big with ALS, a little victory can take on greater meaning, but so can a little loss, says columnist.
The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.
Columnist Dagmar Munn has learned to make accommodations for her ALS to avoid the stress that can accompany holiday events.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results